NCT05824065View on ClinicalTrials.gov

Efficacy and Safety of OMA102 in the Treatment of Female Pattern Hair Loss

PHASE3Not yet recruitingINTERVENTIONAL

Enrollment

504

Participants

Timeline

Start Date

January 31, 2025

Primary Completion Date

January 31, 2027

Study Completion Date

January 31, 2027

Conditions

Female Pattern Baldness

Interventions

DRUG

OMA102

1 mg

DRUG

OMA102

2 mg

DRUG

Placebo

OMA102 - Placebo

Trial Locations (1)

Unknown

EMS, Hortolândia

Sponsors

Lead Sponsor

All Listed Sponsors

lead

EMS

INDUSTRY

NCT05824065 - Efficacy and Safety of OMA102 in the Treatment of Female Pattern Hair Loss | Biotech Hunter | Biotech Hunter